HIGHLIGHTS
- who: Shu-cheng Liu from the School, University of South China, Hengyang, Hunan, China have published the paper: PDCD5 inhibits progression of renal cell carcinoma by promoting T cell immunity: with the involvement of the HDAC3/microRNA-195-5p/SGK1, in the Journal: (JOURNAL)
- what: The authors attempted to uncover the regulatory role of PDCD5 in the development and progression of RCC regarding immune_response. Concordantly, the results in the study showed that miR-195-5p was downregulated in RCC, while downregulation of miR-195-5p counterweighed the anti-tumor action of silencing HDAC3.
-
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.